Carson Wealth (CWM LLC)’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113K Sell
1,767
-224
-11% -$20.4K ﹤0.01% 3152
2025
Q4
$259K Buy
1,991
+67
+3% +$9.2K ﹤0.01% 2354
2025
Q3
$207K Sell
1,924
-226
-11% -$24.6K ﹤0.01% 2418
2025
Q2
$198K Sell
2,150
-340
-14% -$26.7K ﹤0.01% 2178
2025
Q1
$221K Sell
2,490
-283
-10% -$24.6K ﹤0.01% 1856
2024
Q4
$213K Buy
2,773
+682
+33% +$47.6K ﹤0.01% 1791
2024
Q3
$89K Buy
+2,091
New +$70.6K ﹤0.01% 2278

Other funds holding WGS

Carson Wealth (CWM LLC)'s WGS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its GeneDx Holdings (WGS) stake by 11% in Q1 2026, selling an estimated $20.4K and leaving 1,767 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3152.

Carson Wealth (CWM LLC) first reported a position in WGS in Q3 2024 and has held it in 7 quarters since. The position peaked at $259K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,767 shares of GeneDx Holdings worth $113K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 224 GeneDx Holdings shares in Q1 2026, an estimated $20.4K.
  • GeneDx Holdings made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3152 holding.
  • Carson Wealth (CWM LLC) first reported a position in GeneDx Holdings in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s GeneDx Holdings position peaked at $259K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.